樂氏國際控股(01529.HK)上半年淨虧損約1060萬元
格隆匯8月29日丨樂氏國際控股(01529.HK)公佈中期業績,截至2023年6月30日止六個月,2023年上半年集團收益較2022年同期減少約34.8%,2023年首六個月的淨虧損約為人民幣1060萬元,而2022年上半年則約為純利人民幣390萬元。
2023年下半年,在電子商務行業持續擴張、技術進步及政府支持的配合下,預計中國物流業將繼續其疫情後的復甦步伐。中產階級人口持續增長,加上互聯網普及率提高,可能會推動電子商務進一步增長,從而增加對高效物流服務的需求。改善物流基礎設施及引入支援法規的政府措施預計亦將為物流業的增長提供有利環境。預計將非常有必要應對新的監管挑戰並確保合規性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.